cisapride has been researched along with Urinary Bladder, Neurogenic in 4 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with cisapride (4 x 10 mg daily) was undertaken." | 5.27 | Effects of cisapride on constipation due to a neurological lesion. ( de Groot, GH; de Pagter, GF, 1988) |
| "Cisapride was less potent than 5-HT and acted as a partial agonist relative to 5-HT." | 1.32 | Serotonin-induced potentiation of cholinergic responses to electrical field stimulation in normal and neurogenic overactive human detrusor muscle. ( Chapple, CR; Chess-Williams, R; Martin, SW; Radley, SC; Sellers, DJ, 2004) |
| "Treatment with cisapride (4 x 10 mg daily) was undertaken." | 1.27 | Effects of cisapride on constipation due to a neurological lesion. ( de Groot, GH; de Pagter, GF, 1988) |
| "Treatment with Cisapride (R 51 619, Janssen Pharmaceutica) was undertaken in an attempt to increase colonic motility and to reduce urinary retention." | 1.27 | Treatment with cisapride of the gastrointestinal and urological sequelae of spinal cord transection: case report. ( Brassinne, A; Etienne, M; Verlinden, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapple, CR | 1 |
| Radley, SC | 1 |
| Martin, SW | 1 |
| Sellers, DJ | 1 |
| Chess-Williams, R | 1 |
| Wyndaele, JJ | 1 |
| Van Kerrebroeck, P | 1 |
| de Groot, GH | 1 |
| de Pagter, GF | 1 |
| Etienne, M | 1 |
| Verlinden, M | 1 |
| Brassinne, A | 1 |
1 trial available for cisapride and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
The effects of 4 weeks treatment with cisapride on cystometric parameters in spinal cord injury patients. A double-blind, placebo controlled study.
Topics: Adolescent; Adult; Cisapride; Double-Blind Method; Drug Administration Schedule; Female; Humans; Mal | 1995 |
3 other studies available for cisapride and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Serotonin-induced potentiation of cholinergic responses to electrical field stimulation in normal and neurogenic overactive human detrusor muscle.
Topics: Adult; Cisapride; Electric Stimulation; Humans; Middle Aged; Muscle Contraction; Muscle, Smooth; Pip | 2004 |
Effects of cisapride on constipation due to a neurological lesion.
Topics: Adult; Chronic Disease; Cisapride; Constipation; Dose-Response Relationship, Drug; Gastrointestinal | 1988 |
Treatment with cisapride of the gastrointestinal and urological sequelae of spinal cord transection: case report.
Topics: Bisacodyl; Cisapride; Constipation; Drug Administration Schedule; Drug Therapy, Combination; Humans; | 1988 |